Clinical Trial Results Home

Electrophysiology

 Contents
Atrial Fibrillation Trials
Bundle Branch Block
Implantable Cardiac Defibrillator (ICD) and VT / VF
RV and Bi V Pacing
 Atiral Fibrillation Trials

A4: Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation

      -Trial Overview by Dr. Pierre Jais (Heart Rhythm Society Meeting 2006)

ACTIVE A: Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention of Vascular Events - A

      -Effects of Addition of Clopidogrel to Aspirin in Patients with Atrial Fibrillation who are Unsuitable for Vitamin K Antagonists

ACTIVE W: Atrial Fibrillation Clopidogrel Trial with Irbesartan For Prevention of Vascular Events - W

      -Trial Overview by Dr. Stuart J. Connolly (AHA 2005)

APAF: Ablation for Paroxysmal Atrial Fibrillation Trial

      -Trial Overview by Dr. Carlo Pappone (ACC 2006)

 

ARISTOTLE: Apixaban versus Warfarin in Patients with Atrial Fibrillation

      -Trial Results by Dr. Christopher Granger and Dr. Lars Wallentin (ESC 2011)

      -Efficacy and Safety by Dr. Christopher Granger and Dr. Lars Wallentin (ESC 2011)

 

ARISTOTLE Sub-analysis in Japanese patients: Apixaban versus Warfarin in Patients with Atrial Fibrillation

      -Study Overview by Dr. Shinya Goto (ACC 2012)

 

ARISTOTLE CHADS Subgroup Study: Efficacy and Safety of Apixaban Compared with Warfarin According to Patient Risk of Stroke and Bleeding in Atrial Fibrillation

      -Study Overview by Dr. Renato Lopes (ACC 2012)

ATHENA: A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from any Cause in Patients with Atrial Fibrillation/Atrial Flutter

      -Trial Overview by Dr. Stefan H. Hohnloser (Heart Rhythm 2008)

CACAF: Catheter Ablation for the Cure of Atrial Fibrillation Study

      -Trial Overview by Dr. Emanuele Bertaglia (ACC 2005)

 

COPPS: COlchicine for Post-Pericardiotomy Syndrome (COPPS) and Post-Operative Atrial Fibrillation (POAF) Prevention Study

      -Trial Overview by Dr. Massimo Imazio (AHA 2011)

 

Efficacy And Safety Of Prescription Omega-3-Acid Ethyl Esters (P-OM3) For The Prevention Of Recurrent Symptomatic Atrial Fibrillation:

      -Trial Overview by Dr. Peter Kowey (AHA 2010)

 

ESC-EURObservational Research Programme: The Efficacy and Safety Atrial Fibrillation Ablation Conducted by the European Heart Rhythm Association

      -1-Year Follow-Up Results by Dr. Elena Arbelo (ESC 2012)

 

HAS-BLED: A New Simple Novel Risk Score for Predicting Bleeding Risk in an Anticoagulated Atrial Fibrillation Cohort: Validation Against Contemporary Bleeding Risk Schemas

      -Overview by Dr. Gregory Lip

Lone Atrial Fibrillation

      -30-year Follow-up Study in Patients with Lone Atrial Fibrillation by Dr. Arshad Jahangir, et al.

PALLAS: Permanent Atrial FibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy

     -Trial Overview by Dr. Stuart J. Connolly (AHA 2011)

 

PRAGUE-12: A Randomized, Open, Multicenter Study Comparing Cardiac Surgery with MAZE Versus Cardiac Surgery Without MAZE in Patients with Coronary and/or Valvular Heart Disease and With Atrial Fibrillation

      -Trial Overview by Dr. Petr Widimsky (ESC 2012)

PROTECT AF: Percutaneous Closure of the Left Atrial Appendage versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation: A Randomized Non-Inferiority Trial

      -Trial Overview by Dr. David R. Holmes (AHA 2002)

RELY: Randomized Evaluation of Long-term anticoagulant therapY

      -Dabigatran Compared to Warfarin in 18,113 Patients with Atrial Fibrillation at Risk of Stroke

 

ROCKET-AF: Stroke Prevention Using the Oral Direct Factor Xa Inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation

   -Trial Overview by Dr. Kenneth Mahaffey and Dr. Keith Fox (AHA 2010)

SPORTIF III: Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients With Nonvalvular Atrial Fibrillation

      -Trial Overview Presented at ACC 2003

SPORTIF V: Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients With Nonvalvular Atrial Fibrillation

      -Trial Overview by Dr. Jonathan L. Halperin (AHA 2003)

SWEDMAF: The SWEDish Multicentre Atrial Fibrillation study

      -Trial Overview by Dr. Carina Blomstrom-Lundqvist (Heart Rhythm Society Meeting 2006)

Toxicity and Screening Recommendations

      -For Amiodarone Use by Dr. Peter Zimetbaum

(Return to Contents)

 Bundle Branch Block

Cardiac Memory

      -Distinguishing Between Old Versus New Left Bundle Branch Block by Dr. Alexei Shvilkin

(Return to Contents)

 Implantable Cardiac Defibrillator (ICD) and VT / VF

ALPHEE: Double Blind Placebo Controlled Dose Ranging Study Of the Efficacy and Safety Of Celivarone 50, 100, 300 Mg OD with Amiodarone as Calibrator for the Prevention Of ICD Interventions or Death

      -Trial Overview by Dr. Peter Kowey (AHA 2011)

CLARIDI: Cholesterol Lowering and Arrhythmias Recurrences after Internal Defibrillator Implantation Trial

      -Trial Overview by Dr. Johan De Sutter (Heart Rhythm Society Meeting 2006)

 

CRT-D Effectiveness by QRS Duration and Morphology in the MADIT-CRT Patients:

       -Trial Overview by Dr. Wojciech Zareba

DINAMIT: Defibrillator in Acute Myocardial Infarction Trial

      -Trial Overview by Dr. Stewart Connelly and Dr. Stefan H. Hohnloser (ACC 2004)

MADIT II: Multicenter Autonomic Defibrillator Implantation Trial II

      -Trial Overview by Dr. Arthur J. Moss (ACC 2002)

 

MADIT-CRT Reverse Remodeling and the Risk of Ventricular Tachyarrhythmias:

      -Trial Overview by Dr. Alon Barsheshet

OPTIC: Optimal Pharmacological therapy in Implantable Cardioverter Defibrillator Patients

      -Trial Overview by Dr. Stuart J. Connolly (ACC 2005)

SCD-HeFT: Sudden Cardiac Death in Heart Failure Trial

      -All-cause mortality at 5 years by Dr. Gust H. Bardy (ACC 2004)

SMASH-VT: Substrate Mapping And Ablation In Sinus Rhythm To Halt Ventricular Tachycardia

      -Trial Overview by Dr. Vivek Reddy (Heart Rhythm Society 2006)

(Return to Contents)

 RV and Bi V Pacing

BLOCK HF: Biventricular Versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block

     -Preliminary Results by Dr. Anne B. Curtis et al. (AHA 2012)

INTRINSIC RV Trial: Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs Trial

      -Trial Overview by Dr. Brian Olshansky (Heart Rhythm Society Meeting, May 2006)

(Return to Contents)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster